Article
Renal cell carcinoma.
BMJ (Clinical research ed.) - 10 Nov 2014
Jonasch Eric, Gao Jianjun, Rathmell W Kimryn
Abstract excerpt
The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. Progress in the surgical management of the primary tumor and increased understanding of the molecular biology and genomics of the disease have led to the development of new therapeutic agents. The management of the primary tumor has changed owing to the realization that clean margins around the primary lesion are sufficient to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
